Back to User profile » Dr Makoto Okuya
Paper published by Dr Makoto Okuya:
Original Research
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2519-2530
Published Date: 1 October 2018